Search research articles
Contact Us
Filters
Showing results (211-220 of 441) with videos related to
Page
of 45
Sort By:
Cancer
|
July 28, 2005
Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas M.D. Anderson Cancer Center and assessment of prognostic factors
Emer O Hanrahan, Kristine R Broglio, Aman U Buzdar, et al.
Breast Cancer Research and Treatment
|
May 2, 2012
Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells
Bisrat G Debeb, Evan N Cohen, Kimberly Boley, et al.
NPJ Breast Cancer
|
October 11, 2022
Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancer
Hope S Rugo, Adam Brufsky, Xianchen Liu, et al.
Seminars in Cancer Biology
|
October 19, 2019
The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells
Carolina Reduzzi, Marta Vismara, Lorenzo Gerratana, et al.
Ebiomedicine
|
November 1, 2019
A novel strategy to block mitotic progression for targeted therapy
Junlong Jack Chi, Hongchun Li, Zhuan Zhou, et al.
Cancer
|
April 30, 2008
Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy
Jacqueline S Jeruss, Lisa A Newman, Gregory D Ayers, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 20, 2014
Circulating giant macrophages as a potential biomarker of solid tumors
Daniel L Adams, Stuart S Martin, R Katherine Alpaugh, et al.
Cancer
|
January 19, 2010
Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099
Ricardo H Alvarez, Daniel J Booser, Massimo Cristofanilli, et al.
Cancer Research
|
May 28, 2009
Breast cancer metastasis: challenges and opportunities
Jing Lu, Patricia S Steeg, Janet E Price, et al.
Breast Cancer Research and Treatment
|
June 29, 2011
Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patients
Antonio Giordano, Mario Giuliano, Michelino De Laurentiis, et al.
Page
of 45
Search research articles
Search
Showing results (211-220 of 441) with videos related to
Sort By:
Page
of 45
Cancer
|
July 28, 2005
Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas M.D. Anderson Cancer Center and assessment of prognostic factors
Emer O Hanrahan, Kristine R Broglio, Aman U Buzdar, et al.
Breast Cancer Research and Treatment
|
May 2, 2012
Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells
Bisrat G Debeb, Evan N Cohen, Kimberly Boley, et al.
NPJ Breast Cancer
|
October 11, 2022
Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancer
Hope S Rugo, Adam Brufsky, Xianchen Liu, et al.
Seminars in Cancer Biology
|
October 19, 2019
The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells
Carolina Reduzzi, Marta Vismara, Lorenzo Gerratana, et al.
Ebiomedicine
|
November 1, 2019
A novel strategy to block mitotic progression for targeted therapy
Junlong Jack Chi, Hongchun Li, Zhuan Zhou, et al.
Cancer
|
April 30, 2008
Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy
Jacqueline S Jeruss, Lisa A Newman, Gregory D Ayers, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 20, 2014
Circulating giant macrophages as a potential biomarker of solid tumors
Daniel L Adams, Stuart S Martin, R Katherine Alpaugh, et al.
Cancer
|
January 19, 2010
Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099
Ricardo H Alvarez, Daniel J Booser, Massimo Cristofanilli, et al.
Cancer Research
|
May 28, 2009
Breast cancer metastasis: challenges and opportunities
Jing Lu, Patricia S Steeg, Janet E Price, et al.
Breast Cancer Research and Treatment
|
June 29, 2011
Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patients
Antonio Giordano, Mario Giuliano, Michelino De Laurentiis, et al.
Page
of 45